期刊文献+

肾综合征出血热患者循环内皮细胞CD95表达的临床研究

Expression of CD95 on circulating endothelial cells in patients with hemorrhagic fever with renal syndrome
原文传递
导出
摘要 目的探讨肾综合征出血热(HFRS)发热期和多尿期患者循环内皮细胞(CEC)中CD141、CD31及CD95的动态表达及临床意义。方法应用流式细胞术分析不同型HFRS发热期和多尿期患者外周血细胞CD141、CD31及CD95的表达。多组数据的比较采用单因素方差分析。结果HFRS患者发热期和多尿期CD141^+CD31^+细胞(CEC)占外周血细胞的9.47%±1.98%和8.26%±1.55%,高于健康对照者的7.05%±1.45%(F=8.42;P=0.000,P=0.029),且发热期CD141^+CD31^+细胞较多尿期增高(P=0.048)。HFRS发热期及多尿期患者CEC中CD95^+细胞的平均荧光强度(MFD较健康对照者明显升高(F=19.93;P=0.000,P=0.000),且发热期较多尿期明显增高(P=0.049)。发热期各型患者CEC中CD95‘细胞的MFI较健康对照者均明显增高(F=17.36;P=0.000),其中以重(危重)型患者最高,与中型和轻型比较差异有统计学意义(P=0.009,P=0.002)。结论CEC所占比例及CD95表达可能与HFRS病期及病情轻重有关。 Objective To investigate the dynamic expressions and clinical significance of CD141, CD31 and CD95 on circulating endothelial cells (CEC) in febrile and polyuria phases of patients with hemorrhagic fever with renal syndrome (HFRS). Methods Expressions of CD141, CD31 and CD95 in the peripheral blood of patients with HFRS in febrile and polyuria phases were detected by flow cytometry. Comparisons among groups were done by one factor analysis of variance. Results The percentages of CD141+ CD31+ cells in the peripheral blood cells from patients with HFRS in febrile and polyuria phases were 9.47 % ±1.98% and 8.26% ± 1.55 %, respectively, which were both higher than that (7.05%±1.45%) in healthy controls (F=8.42; P=0. 000 and P=0. 029, respectively), and that in febrile phase was higher than that in polyuria phase (P= 0. 048). The mean fluorescent intensity (MFI) of CD95 on CEC of HFRS patients in febrile and polyuria phases were both significantly higher than that in healthy controls (F=lg. 93; P=0. 000 and P 0. 000 respectively), and that in febrile phase was higher than that in polyuria phase (P=0. 049). In the febrile phase of HFRS,the MFI of CD95+ on CEC in patients with all clinical types were all higher than that in healthy controls (F--17.36; all P= 0. 000), and that in severe (critical) type was the highest and higher than those in mild type and moderate type (P=0. 002 and P= 0. 009, respectively). Conclusion The proportion of CEC and expression of CD95 on CEC are possibly related with the phase and severity of HERS.
出处 《中华传染病杂志》 CAS CSCD 北大核心 2009年第8期487-490,共4页 Chinese Journal of Infectious Diseases
关键词 肾综合征出血热 内皮细胞 抗原 CD95 抗原 CD141 抗原 CD31 Hemorrhagic fever with renal syndrome Endothelial cells Antigens, CD95 Antigens, CD141 Antigens,CD31
  • 相关文献

参考文献12

  • 1Takahashi H,Harker LA.Measurement of human endothelial cells in whole blood.Thromb Res,1983,31:1-12.
  • 2盖中涛,张颖,张永,吴世英.肾综合征出血热患者外周血淋巴细胞Fas/FasL表达及与血清sFas/sFasL的相关性研究[J].中华微生物学和免疫学杂志,2002,22(2):145-147. 被引量:5
  • 3Nishimura Y,Ishii A,Kobayashi Y,et al.Expression and function of mouse Fas antigen on immature and mature T cells.J Immunol,1995,154:4395-4403.
  • 4Kagi D,Vignaux F,Ledermann B,et al.Fas and perforin pathways as major mechanisms of T cell-mediated Cytotoxicity.Science,1994,265:528-530.
  • 5朱锡华.Fas系统研究进展[J].中华微生物学和免疫学杂志,1996,16(2):77-82. 被引量:39
  • 6盖中涛,张颖,董格峰,俎燕会,张永,吴世英.肾综合征出血热CD178^+T淋巴细胞本质的临床研究[J].中华实验和临床病毒学杂志,2005,19(4):383-386. 被引量:2
  • 7Scholz D,Schaper J.Platelet/endothelial cell adhesion molecule-1 (PECAM-1)is localized over the entire plasma membrane of endothelial cells.Cell Tissue Res,1997,290:623-631.
  • 8Richard L,Velasco P,Detmar M.A simple immunomagnetic protocol for the selective isolation and longterm culture of human dermal microvascular endothelial cells.Exp Cell Res,1998,240:1-6.
  • 9李宏伟 迟喧 修瑞娟.一种全新的检测循环内皮细胞的方法-流式细胞仪法.中国微循环,1999,11:239-239.
  • 10Ordonez NG.Role of immunobistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas.Am J Surg Pathol,1998,22:1203-1214.

二级参考文献17

  • 1Ju S F,Nature,1995年,373卷,6513期,444页
  • 2Wong G H,J Immunol,1994年,152卷,4期,1751页
  • 3Suda T,Okazaki T,Naito Y,et al.Expression of the Fas ligand in cells of T cell lineage.J Immunol,1995,154:3806-3813.
  • 4Nagata S.Fas ligand-induced apoptosis.Annu Rev Genet,1999,33.29-55.
  • 5Dhein J,Walczak H,Baumler C,et al.Autocrine T-cell suicide mediated by APO-1/.Nature,1995,373:438-441.
  • 6Lenardo,MJ.Fas and the art of lymphocyte maintenance.J Exp Med,1996,183:721.
  • 7Takahashi T,Tanaka M,Brannan CI,et al.Generalized lymphoproliferative disease in mice,caused by a point mutation in the Fas ligand.Cell,1994,76:969-976.
  • 8Watanabe FR,Brannan CI,Copeland NG,et al.Lymphoproliferation disorder in mice explained by defects in fas antigen that mediates apoptosis.Nature,1992,356:314.
  • 9Nagata S,Suda T.Fas and Fas ligand:lpr and gld mutations.Immunol Today,1995.16:39-43.
  • 10Wang C,Splitter GA.CD4+cytotoxic T-lymphocyte activity against macrophages pulsed with bovine herpesvirus 1 polypeptides.J Virol,1998,72:7040-7047.

共引文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部